Page 17 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 11 ฉบับที่ 1
P. 17

Journal of Thai Traditional & Alternative Medicine   Vol. 11 No. 1 January-April 2013  11



              xyflavone · ¥ßƒ∑∏‘Ïμâ“π‡™◊ÈÕ√“ Candida albicans  ¿“¬„π 1-2 ™—Ë«‚¡ßÀ≈—ß„À⬓ ‚¥¬¡’ bioavailability
                                                    16
              ·≈–· ¥ßƒ∑∏‘Ïμâ“π‡™◊ÈÕ Mycobacterium Õ¬à“ßÕàÕπ  μË”·§à 1-4%, æ∫°√–®“¬‰ª¬—ßÕ«—¬«–¿“¬„πμà“ßÊ
                  9. ƒ∑∏‘Ïμâ“π°“√‡°‘¥·º≈„π°√–‡æ“–Õ“À“√   ‚¥¬¡’√–¥—∫ Ÿß ÿ¥„πμ—∫ √Õß≈ß¡“§◊Õ‰μ, ¢—∫ÕÕ°
                  ‡¡◊ËÕ„Àâ “√ °—¥°√–™“¬¥”¥â«¬‡Õ∑“πÕ≈„π   ∑“ßªí  “«–„π√Ÿª¢Õß demethylated, sulfated ·≈–

              ¢π“¥ 30, 60 ·≈– 120 ¡°./°°. ·°àÀπŸ·√μ æ∫«à“  glucuronidated ·≈–¢—∫ÕÕ°∑“ßÕÿ®®“√–„π√Ÿª¢Õß
                                                                          49
              ¡’ƒ∑∏‘Ϭ—∫¬—Èß°“√‡°‘¥·º≈„π°√–‡æ“–Õ“À“√‡π◊ËÕß®“°  demethylated form
              ‰¥â√—∫¬“Õ‘π‚¥‡¡∑“´‘π À√◊Õ°√¥‡°≈◊Õ√à«¡°—∫
                                                         √“¬ß“π°“√«‘®—¬∑“ߧ≈‘π‘°
              ·Õ≈°ÕŒÕ≈åÀ√◊Õ®“°§«“¡‡§√’¬¥¥â«¬°“√„ÀâÕ¬Ÿà„π∑’Ë
              ·§∫√à«¡°—∫°“√·™à„ππÈ” ‚¥¬‰¡à¡’º≈μàÕª√‘¡“μ√      1. º≈μàÕ physical fitness „πºŸâ ŸßÕ“¬ÿ

              ¢ÕßπÈ”¬àÕ¬„π°√–‡æ“– §à“§«“¡‡ªìπ°√¥ (pH) ·≈–     ∑¥ Õ∫„πÕ“ “ ¡—§√ ŸßÕ“¬ÿ ÿ¢¿“楒®”π«π
              °“√À≈—Ëß°√¥ ·μà√—°…“°“√À≈—Ë߇¡◊Õ°„π°√–‡æ“– (gas-  45 √“¬ ‚¥¬ ÿà¡„Àâ√—∫ª√–∑“π¬“À≈Õ°À√◊Õ “√ °—¥
                        47
              tric mucus)                                °√–™“¬¥”À¬“∫ª√‘¡“≥ 25 À√◊Õ 90 ¡°./«—π‡ªìπ‡«≈“
                  10. º≈μàÕ cytochrome P450 enzymes      8  —ª¥“Àå »÷°…“º≈μàÕ ¡√√∂¿“æ√à“ß°“¬ (health-
                  ‡¡◊ËÕ»÷°…“„π microsome ∑’ˇμ√’¬¡®“°μ—∫  related physical fitness) ‚¥¬„Àâπ—Ëß-¬◊π 30 «‘π“∑’,

              ÀπŸ∂’∫®—°√ æ∫«à“ “√ °—¥°√–™“¬¥”¡’º≈μàÕ     °“√«—¥·√ß∫’∫¡◊Õ, √–¬–∑“ß∑’ˇ¥‘π„π 6 π“∑’·≈–
              CYP1A2 ·≈– CYP2B ·≈–‡¡◊ËÕ„ÀâÀπŸ∂’∫®—°√°‘π  √–¬–‡«≈“∑’ˬ◊π‚¥¬«“߇∑â“μàÕ°—π  ≈—∫´â“¬¢«“ ·≈–
               “√ °—¥¢π“¥ 250 ¡°./°°. π“π 7, 14 ·≈– 21 «—π  ‡¡◊ËÕ≈◊¡μ“·≈–À≈—∫μ“ (tandem stance test),

              æ∫«à“‰¡à¡’º≈μàÕ CYP3A activity ·μà¡’º≈°√–μÿâπ  «‘‡§√“–Àåª√‘¡“≥ malondialdehde (MDA) ‡Õπ‰´¡å
              activities ¢Õß CYP1A1, CYP1A2 À≈—߉¥â√—∫ “√  superoxide dismutase (SOD), catalase (CAT),
               °—¥™à«ß‡«≈“ —ÈπÊ,  à«π activity ¢Õß CYP2B  ·≈– glutathione peroxidase (GSH-Px) æ∫«à“

              ‡æ‘Ë¡¢÷Èπμ≈Õ¥∑ÿ°™à«ß‡«≈“∑’Ë„Àâ “√ °—¥, ¢≥–∑’Ë acti-  °√–™“¬¥”™à«¬‡æ‘Ë¡ ¡√√∂¿“æ„π°“√π—Ëß-¬◊π 30
              vity ¢Õß CYP2E1 ‡æ‘Ë¡¢÷Èπ‡©æ“–‡¡◊ËÕ„Àâ “√ °—¥  «‘π“∑’·≈–‡¥‘π 6 π“∑’ æ√âÕ¡°—∫‡æ‘Ë¡ activity ¢Õß
                             48
              ‡ªìπ‡«≈“π“π‡∑à“π—Èπ                        scavengerenzymes ∑ÿ°™π‘¥¢â“ßμâπ ¢≥–∑’Ë√–¥—∫
                  11. ‡¿ —™®≈π»“ μ√å¢Õß “√°≈ÿà¡ Metho-   MDA ≈¥≈ß ¥—ßπ—Èπ°√–™“¬¥”®÷ߙ૬‡æ‘Ë¡§«“¡·¢Áß
              xyflavones „πÀπŸ·√μ                        ·√ß√à“ß°“¬„πºŸâ ŸßÕ“¬ÿ  à«πÀπ÷Ë߇π◊ËÕß®“°ƒ∑∏‘Ï≈¥¿“«–
                                                                       50
                  ®“°√“¬ß“π°“√»÷°…“‡¿ —™®≈π»“ μ√å¢Õß     oxidative stress
               “√ °—¥‡Õ∑“πÕ≈„πÀπŸ∂’∫®—°√‚¥¬„Àâ “√ °—¥¢π“¥     2. º≈‡©’¬∫æ≈—π¢Õß°√–™“¬¥”μàÕ§«“¡
              750 ¡°./°°. ∑“ߪ“° μ‘¥μ“¡ “√°≈ÿà¡ methoxy-   “¡“√∂„π°“√ÕÕ°°”≈—ß°“¬

              flavones ‚¥¬‡©æ“–Õ¬à“߬‘Ëß 5,7-dimethoxyflavone  √“¬ß“π°“√»÷°…“º≈‡©’¬∫æ≈—π¢Õß°√–™“¬
              (DMF), 5,7,4'-trimethoxyflavone (TMF), and  ¥”·§ª´Ÿ≈‡∑’¬∫°—∫¬“À≈Õ°μàÕ§«“¡ “¡“√∂„π°“√

              3,5,7,3',4'-pentamethoxyflavone (PMF) æ∫«à“  ÕÕ°°”≈—ß°“¬ ‚¥¬°“√»÷°…“·√°∑¥ Õ∫º≈μàÕ°“√
               “√ methoxyflavones ¢÷Èπ∂÷ß√–¥—∫ Ÿß ÿ¥„π‡≈◊Õ¥  ªíòπ®—°√¬“π‡√Á«∑’Ë ÿ¥π“π 30 «‘π“∑’ μàÕ°—π 3 §√—Èß
   12   13   14   15   16   17   18   19   20   21   22